318 related articles for article (PubMed ID: 24737393)
1. Notch signaling in prostate cancer: a moving target.
Carvalho FL; Simons BW; Eberhart CG; Berman DM
Prostate; 2014 Jun; 74(9):933-45. PubMed ID: 24737393
[TBL] [Abstract][Full Text] [Related]
2. HES6 promotes prostate cancer aggressiveness independently of Notch signalling.
Carvalho FL; Marchionni L; Gupta A; Kummangal BA; Schaeffer EM; Ross AE; Berman DM
J Cell Mol Med; 2015 Jul; 19(7):1624-36. PubMed ID: 25864518
[TBL] [Abstract][Full Text] [Related]
3. Notch signaling dynamics in the adult healthy prostate and in prostatic tumor development.
Pedrosa AR; Graça JL; Carvalho S; Peleteiro MC; Duarte A; Trindade A
Prostate; 2016 Jan; 76(1):80-96. PubMed ID: 26419726
[TBL] [Abstract][Full Text] [Related]
4. Notch signaling in the prostate: critical roles during development and in the hallmarks of prostate cancer biology.
Deng G; Ma L; Meng Q; Ju X; Jiang K; Jiang P; Yu Z
J Cancer Res Clin Oncol; 2016 Mar; 142(3):531-47. PubMed ID: 25736982
[TBL] [Abstract][Full Text] [Related]
5. Notch signaling in prostate cancer: refining a therapeutic opportunity.
Su Q; Xin L
Histol Histopathol; 2016 Feb; 31(2):149-57. PubMed ID: 26521657
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Notch Signalling Pathway Members in Normal Prostate, Prostatic Intraepithelial Neoplasia (PIN) and Prostatic Adenocarcinoma.
Soylu H; Acar N; Ozbey O; Unal B; Koksal IT; Bassorgun I; Ciftcioglu A; Ustunel I
Pathol Oncol Res; 2016 Jan; 22(1):87-94. PubMed ID: 26341090
[TBL] [Abstract][Full Text] [Related]
7. Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression.
Alaña L; Sesé M; Cánovas V; Punyal Y; Fernández Y; Abasolo I; de Torres I; Ruiz C; Espinosa L; Bigas A; Y Cajal SR; Fernández PL; Serras F; Corominas M; Thomson TM; Paciucci R
Mol Cancer; 2014 Mar; 13():74. PubMed ID: 24684754
[TBL] [Abstract][Full Text] [Related]
8. Notch promotes tumor metastasis in a prostate-specific Pten-null mouse model.
Kwon OJ; Zhang L; Wang J; Su Q; Feng Q; Zhang XH; Mani SA; Paulter R; Creighton CJ; Ittmann MM; Xin L
J Clin Invest; 2016 Jul; 126(7):2626-41. PubMed ID: 27294523
[TBL] [Abstract][Full Text] [Related]
9. Tumor-suppressive activity of Lunatic Fringe in prostate through differential modulation of Notch receptor activation.
Zhang S; Chung WC; Wu G; Egan SE; Xu K
Neoplasia; 2014 Feb; 16(2):158-67. PubMed ID: 24709423
[TBL] [Abstract][Full Text] [Related]
10. A conserved mechanism for JNK-mediated loss of Notch function in advanced prostate cancer.
Wang CW; Clémot M; Hashimoto T; Diaz JA; Goins LM; Goldstein AS; Nagaraj R; Banerjee U
Sci Signal; 2023 Nov; 16(810):eabo5213. PubMed ID: 37934809
[TBL] [Abstract][Full Text] [Related]
11. Notch signaling: a potential therapeutic target in prostate cancer.
Villaronga MA; Bevan CL; Belandia B
Curr Cancer Drug Targets; 2008 Nov; 8(7):566-80. PubMed ID: 18991567
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological inhibition of the Notch pathway enhances the efficacy of androgen deprivation therapy for prostate cancer.
Cui J; Wang Y; Dong B; Qin L; Wang C; Zhou P; Wang X; Xu H; Xue W; Fang YX; Gao WQ
Int J Cancer; 2018 Aug; 143(3):645-656. PubMed ID: 29488214
[TBL] [Abstract][Full Text] [Related]
13. Notch activation by phenethyl isothiocyanate attenuates its inhibitory effect on prostate cancer cell migration.
Kim SH; Sehrawat A; Sakao K; Hahm ER; Singh SV
PLoS One; 2011; 6(10):e26615. PubMed ID: 22039516
[TBL] [Abstract][Full Text] [Related]
14. Synergistic Activity with NOTCH Inhibition and Androgen Ablation in ERG-Positive Prostate Cancer Cells.
Mohamed AA; Tan SH; Xavier CP; Katta S; Huang W; Ravindranath L; Jamal M; Li H; Srivastava M; Srivatsan ES; Sreenath TL; McLeod DG; Srinivasan A; Petrovics G; Dobi A; Srivastava S
Mol Cancer Res; 2017 Oct; 15(10):1308-1317. PubMed ID: 28607007
[TBL] [Abstract][Full Text] [Related]
15. Notch activation is dispensable for D, L-sulforaphane-mediated inhibition of human prostate cancer cell migration.
Hahm ER; Chandra-Kuntal K; Desai D; Amin S; Singh SV
PLoS One; 2012; 7(9):e44957. PubMed ID: 22970326
[TBL] [Abstract][Full Text] [Related]
16. The Notch-1 receptor in prostate tumorigenesis.
O'Brien R; Marignol L
Cancer Treat Rev; 2017 May; 56():36-46. PubMed ID: 28457880
[TBL] [Abstract][Full Text] [Related]
17. Dual tumor suppressing and promoting function of Notch1 signaling in human prostate cancer.
Lefort K; Ostano P; Mello-Grand M; Calpini V; Scatolini M; Farsetti A; Dotto GP; Chiorino G
Oncotarget; 2016 Jul; 7(30):48011-48026. PubMed ID: 27384993
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of Notch-1 and Jagged-1 inhibits prostate cancer cell growth, migration and invasion, and induces apoptosis via inactivation of Akt, mTOR, and NF-kappaB signaling pathways.
Wang Z; Li Y; Banerjee S; Kong D; Ahmad A; Nogueira V; Hay N; Sarkar FH
J Cell Biochem; 2010 Mar; 109(4):726-36. PubMed ID: 20052673
[TBL] [Abstract][Full Text] [Related]
19. Wnt and Notch pathways have interrelated opposing roles on prostate progenitor cell proliferation and differentiation.
Shahi P; Seethammagari MR; Valdez JM; Xin L; Spencer DM
Stem Cells; 2011 Apr; 29(4):678-88. PubMed ID: 21308863
[TBL] [Abstract][Full Text] [Related]
20. Role of notch-1 and E-cadherin in the differential response to calcium in culturing normal versus malignant prostate cells.
Dalrymple S; Antony L; Xu Y; Uzgare AR; Arnold JT; Savaugeot J; Sokoll LJ; De Marzo AM; Isaacs JT
Cancer Res; 2005 Oct; 65(20):9269-79. PubMed ID: 16230388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]